Day: March 2, 2021

Why doctors say not to compare efficacy of COVID-19 vaccines,

U.S. clinical trials found the Johnson & Johnson’s vaccine is 72% effective. This video file cannot be played …, U.S. clinical trials found the Johnson & Johnson’s vaccine is 72% effective. This video file cannot be played …, Read More

Pregnant women’s appetite for risk,

This concern extends to vaccinations, and a review of WHO-registered COVID-19 clinical trials found that all nine vaccine trials explicitly excluded …, This concern extends to vaccinations, and a review of WHO-registered COVID-19 clinical trials found that all nine vaccine trials explicitly excluded …, Read More

An interactive website tracking COVID-19 vaccine development,

Our clinical trials database includes 156 registered studies spanning 70 separate candidates, of which 20 are currently undergoing phase 3 efficacy …, Our clinical trials database includes 156 registered studies spanning 70 separate candidates, of which 20 are currently undergoing phase 3 efficacy …, Read More

Camargo Pharmaceutical Services Acquires Paidion Research,

Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Read …

Camargo Pharmaceutical Services Acquires Paidion Research, Read More »

Camargo Pharmaceutical Services Acquires Paidion Research,

Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Read …

Camargo Pharmaceutical Services Acquires Paidion Research, Read More »

Camargo Pharmaceutical Services Acquires Paidion Research,

Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) …, Read …

Camargo Pharmaceutical Services Acquires Paidion Research, Read More »

Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call,

Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic …, Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic …, Read More

Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call,

Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic …, Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic …, Read More

Scroll to Top